Impact of the Neglected Tropical Diseases on Human Development in the Organisation of Islamic Cooperation Nations

The employment of a new “worm index” of human development, together with additional published health information, confirms the important role neglected tropical diseases (NTDs) play in hindering the advancement of many of the world’s Muslim-majority countries.

Read the article here:

http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0003782

 

 

Neglected Tropical Diseases in the Ebola-Affected Countries of West Africa

While global attention in West Africa is focused on the emergence of Ebola virus infection, new information from the published literature and World Health Organization databases reveals that many other neglected tropical diseases (NTDs) are far more widespread and also require urgent attention.

http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0003671

Boko Haram and Africa’s Neglected Tropical Diseases

Currently the four nations under threat by Boko Haram account for approximately one third each of the 169 million people at risk for onchocerciasis (river blindness, and the estimated 472 million people who require mass treatment for lymphatic filariasis (LF), elephantiasis, in Africa. Moreover, transmission of Gambian human African trypanosomiasis (HAT) still occurs in Cameroon, Chad, and possibly Niger.

Read the whole post here

The Onchocerciasis Vaccine for Africa—TOVA—Initiative

Hotez et al.

An onchocerciasis vaccine for Africa would build on past investments in OCP and APOC and support future investments planned under PENDA to help achieve elimination of onchocerciasis. TOVA has begun to explore innovative financing mechanisms from major foundations, governments in North America, Europe, and elsewhere, as well as some of the major development banks committed to poverty reduction in sub-Saharan Africa. We strongly encourage the global public health community to embrace the prospect of an onchocerciasis vaccine and to incorporate plans for a vaccine’s development into future public policy and strategic plan considerations.

Read the rest of the article here